Literature DB >> 15851790

Adjuvant therapy in stage II colon cancer: current approaches.

Lisa Baddi1, Al Benson.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15851790     DOI： 10.1634/theoncologist.10-5-325

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  13 in total

1.  Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer.

Authors:  Yoshinaga Okugawa; Yuji Toiyama; Shusuke Toden; Hiroki Mitoma; Takeshi Nagasaka; Koji Tanaka; Yasuhiro Inoue; Masato Kusunoki; C Richard Boland; Ajay Goel
Journal:  Gut       Date:  2015-10-15       Impact factor: 23.059

Review 2.  Adjuvant therapies for colorectal cancer.

Authors:  Suzanne Kosmider; Lara Lipton
Journal:  World J Gastroenterol       Date:  2007-07-28       Impact factor: 5.742

Review 3.  Microsatellite instability in colorectal cancer-the stable evidence.

Authors:  Eduardo Vilar; Stephen B Gruber
Journal:  Nat Rev Clin Oncol       Date:  2010-02-09       Impact factor: 66.675

4.  The impact of age on quality measure adherence in colon cancer.

Authors:  Scott R Steele; Steven L Chen; Alexander Stojadinovic; Aviram Nissan; Kangmin Zhu; George E Peoples; Anton Bilchik
Journal:  J Am Coll Surg       Date:  2011-05-20       Impact factor: 6.113

5.  Elevated serum DAND5 is associated with metastasis and predicts poor prognosis in colorectal cancer.

Authors:  Xiaofei Miao; Ye Zhang; Jialin Sun; Songkui Cui; Qingyang Meng; Kuiyu Zhu; Xingqian Hu; Tong Wang
Journal:  United European Gastroenterol J       Date:  2016-10-12       Impact factor: 4.623

6.  AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancer.

Authors:  Kunitoshi Shigeyasu; Yoshinaga Okugawa; Shusuke Toden; Jinsei Miyoshi; Yuji Toiyama; Takeshi Nagasaka; Naoki Takahashi; Masato Kusunoki; Tetsuji Takayama; Yasuhide Yamada; Toshiyoshi Fujiwara; Leilei Chen; Ajay Goel
Journal:  JCI Insight       Date:  2018-06-21

Review 7.  A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy.

Authors:  Vanessa Deschoolmeester; Marc Baay; Pol Specenier; Filip Lardon; Jan B Vermorken
Journal:  Oncologist       Date:  2010-06-28

8.  High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients.

Authors:  Boye Schnack Nielsen; Stine Jørgensen; Jacob Ulrik Fog; Rolf Søkilde; Ib Jarle Christensen; Ulla Hansen; Nils Brünner; Adam Baker; Søren Møller; Hans Jørgen Nielsen
Journal:  Clin Exp Metastasis       Date:  2010-10-31       Impact factor: 5.150

Review 9.  What is the optimal means of staging colon cancer?

Authors:  Elizabeth A Arena; Anton J Bilchik
Journal:  Adv Surg       Date:  2013

Review 10.  The role of molecular markers in predicting response to therapy in patients with colorectal cancer.

Authors:  Veena Shankaran; Kari B Wisinski; Mary F Mulcahy; Al B Benson
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.